Chosen Diagnostics is to improve health care delivery for patients by personalizing their medicine.
A biomarker test to diagnose a common and life-threatening bowel disease in preterm infants. It offers more accurate results than current options and allows earlier medical intervention.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Oct 19, 2021 | Grant | $2.10M | 1 |
National Institutes of Health
|
— | Detail |
| May 28, 2020 | Grant | $224.75K | 1 |
National Science Foundation
|
— | Detail |
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
National Institutes of Health
|
Yes | Grant |
National Science Foundation
|
Yes | Grant |